These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7508010)

  • 1. Role of ouabain-like factors in hypertension: effects of ouabain and certain endogenous ouabain-like factors in hypertension.
    Yuan C; Manunta P; Chen S; Hamlyn JM; Haddy FJ; Pamnani MB
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S10-2. PubMed ID: 7508010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of three sodium-potassium adenosine triphosphatase inhibitors.
    Pamnani MB; Chen S; Bryant HJ; Schooley JF; Eliades DC; Yuan CM; Haddy FJ
    Hypertension; 1991 Sep; 18(3):316-24. PubMed ID: 1653768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic blood pressure effects of bufalin, a sodium-potassium ATPase inhibitor, in rats.
    Pamnani MB; Chen S; Yuan CM; Haddy FJ
    Hypertension; 1994 Jan; 23(1 Suppl):I106-9. PubMed ID: 8282340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis.
    Hamlyn JM; Hamilton BP; Manunta P
    J Hypertens; 1996 Feb; 14(2):151-67. PubMed ID: 8728291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term ouabain administration produces hypertension in rats.
    Yuan CM; Manunta P; Hamlyn JM; Chen S; Bohen E; Yeun J; Haddy FJ; Pamnani MB
    Hypertension; 1993 Aug; 22(2):178-87. PubMed ID: 8340153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
    Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the role of sodium- and potassium-activated adenosine triphosphatase inhibition in the pathogenesis of human hypertension. Changes in vascular and cardiac function following inhibition of the sodium pump in normotensive subjects and effects of calcium entry blockade.
    Kramer HJ; Glänzer K; Freitag T; Schönfeld J; Sorger M; Schlebusch H; Düsing R; Krück F
    Klin Wochenschr; 1985 Jan; 63(1):32-6. PubMed ID: 2579261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of direct renal arterial infusion of bufalin and ouabain in conscious sheep.
    Yates NA; McDougall JG
    Br J Pharmacol; 1993 Mar; 108(3):627-30. PubMed ID: 8385530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different effects of in vivo ouabain and digoxin on renal artery function and blood pressure in the rat.
    Kimura K; Manunta P; Hamilton BP; Hamlyn JM
    Hypertens Res; 2000 Sep; 23 Suppl():S67-76. PubMed ID: 11016823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Na+-K+-ATPase inhibitors and renin release: relationship to calcium.
    Cruz-Soto M; Benabe JE; López-Novoa JM; Martínez-Maldonado M
    Am J Physiol; 1984 Oct; 247(4 Pt 2):F650-5. PubMed ID: 6093556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin.
    Manunta P; Hamilton J; Rogowski AC; Hamilton BP; Hamlyn JM
    Hypertens Res; 2000 Sep; 23 Suppl():S77-85. PubMed ID: 11016824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ouabain on blood pressure regulation in rats.
    Yasujima M; Abe K; Tanno M; Kohzuki M; Kasai Y; Sato M; Omata K; Takeuchi K; Yoshinaga K; Masugi F
    J Hypertens; 1986 Oct; 4(5):597-601. PubMed ID: 3025297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In ability of Na+,K+-ATPase inhibitor to cause hypertension in sodium-loaded or deoxycorticosterone-treated one kidney rats.
    Nirasawa Y; Temma K; Fink GD; Akera T
    Life Sci; 1985 Aug; 37(8):767-74. PubMed ID: 2991692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factors.
    Gonick HC; Weiler EW; Prins BA; Purdy RE
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S69-71. PubMed ID: 7508033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factor(s) from the venom of Bufo marinus toad.
    Bagrov AY; Roukoyatkina NI; Fedorova OV; Pinaev AG; Ukhanova MV
    Eur J Pharmacol; 1993 Apr; 234(2-3):165-72. PubMed ID: 8387009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of canrenone on blood pressure in rats with reduced renal mass.
    Pamnani MB; Whitehorn WV; Clough DL; Haddy FJ
    Am J Hypertens; 1990 Mar; 3(3):188-95. PubMed ID: 2157466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ouabain-dependent Na(+)-K+ pump and the brain renin-angiotensin system.
    Doursout MF; Chelly JE; Liang YY; Buckley JP
    Clin Exp Hypertens A; 1992; 14(3):393-411. PubMed ID: 1318174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ouabain-like factors and Na-K-ATPase inhibitors in hypertension--some old and recent findings.
    Haddy FJ; Pamnani MB
    Clin Exp Hypertens; 1998; 20(5-6):499-508. PubMed ID: 9682906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ouabain on hemodynamics in acute volume expanded hypertensive dogs.
    Otsuka A; Mikami H; Kohara K; Katahira K; Tsunetoshi T; Ogihara T
    Basic Res Cardiol; 1989; 84(3):319-25. PubMed ID: 2548471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.